NCT03831776
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03831776
Title Long-acting Low Dose Ropeginterferon for Chronic Myeloid Leukemia Treated With Bosutinib From Diagnosis (BosuPeg)
Acronym BosuPeg
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors St. Olavs Hospital
Indications
Therapies
Age Groups: adult | senior
Covered Countries SWE | NOR | FIN | DNK

Facility Status City State Zip Country Details
Aalborg university hospital Aalborg Denmark Details
Aarhus ... Aarhus Denmark Details
Copenhagen ... Copenhagen Denmark Details
Odense Universitetshospital Odense Denmark Details
Comprehensive Cancer Center, Hematology Helsinki Finland Details
Haukeland Universitetssjukehus Bergen Norway Details
Oslo Universitetssykehus Oslo Norway Details
Stavanger Universitetssjukehus Stavanger Norway Details
Universitetssykehuset Nord Norge Tromsø Norway Details
St Olavs Hospital Trondheim Norway Details
Göteborg .... Gothenburg Sweden Details
Universitetssjukhuset Linköping Linköping Sweden Details
Skåne University Hospital Lund Sweden Details
Universitetssjukhuset Örebro Örebro Sweden Details
Karolinska Universitetssjukhus Stockholm Sweden Details
Sundsvall ... Sundsvall Sweden Details
Norrlands Universitetssjukhus Umeå Sweden Details
University Hospital Uppsala Sweden Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field